Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Salicylate accumulation kinetics in man.

× No keyword cloud information.

49 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

Review 2. Nonlinear pharmacokinetics: clinical Implications.

Authors: T M Ludden
Journal: Clin Pharmacokinet Date: 1991-06 Impact factor: 6.447

3. Perspectives on the history and scientific contributions of Gerhard Levy.

Authors: Ho-Leung Fung; William J Jusko
Journal: J Pharmacokinet Pharmacodyn Date: 2015-09-24 Impact factor: 2.745

4. Interaction of indomethacin and acetylsalicylic acid as shown by the serum concentrations of indomethacin and salicylate.

Authors: E Kaldestad; T Hansen; H K Brath
Journal: Eur J Clin Pharmacol Date: 1975-12-19 Impact factor: 2.953

5. Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.

Authors: Timothy J Zumwalt; Dominik Wodarz; Natalia L Komarova; Shusuke Toden; Jacob Turner; Jacob Cardenas; John Burn; Andrew T Chan; C Richard Boland; Ajay Goel
Journal: Cancer Prev Res (Phila) Date: 2017-02-02

6. Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors: Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal: Pharm Res Date: 2007-09-11 Impact factor: 4.200

7. 'MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics.

Authors: R Bloch; G Sweeney; K Ahmed; C J Dickinson; D Ingram
Journal: Br J Clin Pharmacol Date: 1980-12 Impact factor: 4.335

8. Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Authors: L Kristin Newby; Manjushri V Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Journal: J Thromb Thrombolysis Date: 2003-12 Impact factor: 2.300

9. Alleviation of mortality induced by salicylate and stress.

Authors: P J Jastreboff; J F Brennan
Journal: Experientia Date: 1994-05-15

10. Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.

Authors: J Shen; S Wanwimolruk; R D Purves; E G McQueen; M S Roberts
Journal: J Pharmacokinet Biopharm Date: 1991-10